JPRN-jRCT2080220359未知3 期
ong term study of Valsartan and Amlodipine in patients with essential hypertension (extension from Study CVAA489A1301)
ovartis Pharma K.K.0 个研究点目标入组 400 人开始时间: 2007年3月14日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Inclusion criteria
- •- Participation in Study CVAA489A1301
- •- Patients whose blood pressure at Visit 7 of the Study CVAA489A1301 trial was well controlled
- •- Male or female outpatients
- •Exclusion criteria
- •- Presence of major protocol violation in Study CVAA489A1301
- •- Patients who experienced any adverse events considered serious and drug related in Study CVAA489A1301
- •Other protocol-defined inclusion/exclusion criteria may apply
排除标准
- 未提供
研究者
相似试验
已完成
4 期
The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic DysfunctionDiastolic DysfunctionHypertensionNCT00523549Novartis Pharmaceuticals229
招募中
Unknown
Bioequivalence study of Amlodipine/Valsartan tabletIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N54Tabriz University of Medical Sciences24
已完成
3 期
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With HypertensionHypertensionNCT00413049Novartis698
尚未招募
不适用
Bioeqivalence study of amlodipine valsartan 10/160 mg tabletBioequivalence study.IRCT20220209053979N5Alborz Darou24
进行中（未招募）
不适用
A TElmisartan and AMlodipine STudy to Assess the cardiovascular PROTECTive effects as measured by endothelial dysfunction in hypertensive at risk patients beyond blood pressure - TEAMSTA PROTECT I?Male and female, treated and treatment-naive patients with uncontrolled hypertension (defined as 20/10 mmHg above target BP of <140/90 mmHg [<130/80 mmHg for renally impaired and/ or diabetics patients])?Male and female treated patients with controlled hypertension (defined as target BP < 140/90 mmHg [ < 130/80 mmHg for renally impaired and/ or diabetics patients])MedDRA version: 13.1Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2009-017010-68-DEniversitätsmedizin der Johannes Gutenberg-Universität Mainz